Inmunomodulación y Microambiente Tumoral
ITAM
![Foto de Inmunomodulación y Microambiente Tumoral](/img/uploaded/c0b38ccda2541aecc1b9d759d57af663.jpg)
![Foto de NavarraBiomed](/img/noimage_org.png)
NavarraBiomed
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de NavarraBiomed (3)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
2022
-
CAR-T Cells for the Treatment of Lung Cancer
Life, Vol. 12, Núm. 4
2021
-
Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model
Journal of Nanobiotechnology, Vol. 19, Núm. 1